Our study reveals a new mechanism by which diabetes accelerates vascular senescence and identifies the pharmacological effect of FGF21 in mitigating diabetes-induced vascular senescence, providing new evidence for its potential clinical application. Here, FGF21 is linked to diabetes mellitus.